Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Etude de Phase II évaluant l'immunogénicité et la tolérance d'un Vaccin inactivé Non adjuvanté Contre la Grippe A(H1N1)v Chez la Femme Enceinte

NCT01024400 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT01024400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01024400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Etude de Phase II évaluant l'immunogénicité et la tolérance d'un Vaccin inactivé Non adjuvanté Contre la Grippe A(H1N1)v Chez la Femme Enceinte
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
July 31, 2010
Enrollment
110 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

influenza